Drug major Lupin on Monday announced partnership with Eli Lilly and Company (India) to distribute Eli Lilly’s diabetes injection Aplevant in the country. Lupin said the expansion of the business partnership with Eli Lilly is aimed at widening access to diabetes medicines in India. Lupin will distribute and market Lilly’s Aplevant (dulaglutide), once a weekly injection for type 2 diabetes treatment, it said in a regulatory filing.
